Strategic Acquisition XVIVO Abdominal’s acquisition of Organ Assist and its continuing focus on oxygenated machine perfusion across kidney, liver, and lung applications signals potential cross-sell opportunities for integrated perfusion solutions, training programs, and expanded service sets to hospitals and transplant centers already familiar with Organ Assist technology.

Clinical Education Organ Assist Academy offers tailored theoretical and practical training on device assembly, troubleshooting, and procedure simulation. Targeting transplant centers and perfusion teams with a need for upskilling presents a pathway to increase device adoption and customer loyalty.

Global Expansion XVIVO’s involvement in international conferences and ongoing partnerships, plus recent leadership updates, indicates momentum in global market penetration. Sales teams should pursue new center registrations, expand to European and Latin American networks, and align with strategic partners.

Product Differentiation Devices feature common user interfaces, adjustable perfusion temperatures, and pulsatile flow with organ-specific pre-sets, positioning XVIVO as a premium, turnkey perfusion solution. Emphasize lifecycle value, training ease, and CE approvals to justify higher adoption in transplant programs.

Revenue Opportunity With a revenue base under one million and a broad device portfolio across organs, there is room to upsell service contracts, extended warranties, and scalable training packages to existing and new customers, plus potential expansion into related perfusion devices and consultative support for NRPs and transport.